Fennec Pharmaceuticals Inc.
IPOHearing Loss in Chemotherapy | Pedmark | Fennec Pharmaceuticals
Public · Durham, United States · Founded 1996 · $47.9M raised
- Headquarters
- Durham, North Carolina
- Employees
- 1–10
- Founded
- 1996
- Business Model
- B2B
- Website
- fennecpharma.com
- Total Funding
- $47.9M
- Last Round
- $40.3M Corporate RoundNov 2025
- Rounds
- 2
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Fennec Pharmaceuticals is a commercial-stage specialty pharma company focused on PEDMARK, a therapy to reduce chemotherapy-induced hearing loss in children.
Summary
Fennec Pharmaceuticals Inc. is a Biotech company based in Durham, United States, founded in 1996. It has raised $47.9M in total across 2 rounds, most recently a $40.3M Corporate Round in Nov 2025. Investors include Piper Sandler, Craig-Hallum Capital Group and H.C. Wainwright & Co..
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Nov 2025
Sign up to see all 3 events
Funding: Corporate Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/fennec-pharmaceuticals-inc"><img src="https://indexed.vc/api/badge/company/fennec-pharmaceuticals-inc" alt="Fennec Pharmaceuticals Inc. on Indexed.vc" width="260" height="76" /></a>